Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Proteins stereoselective

Phenylbutazone Potentiation (213) Displacement from binding sites on plasma proteins stereoselective inhibition of metabolism (warfarin) causes peptic ulceration (214,215) Avoid concurrent use... [Pg.991]

Although most anesthetics are achiral or are adininistered as racemic mixture, the anesthetic actions are stereoselective. This property can define a specific, rather than a nonspecific, site of action. Stereoselectivity is observed for such barbiturates as thiopental, pentobarbital, and secobarbital. The (3)-enantiomer is modestly more potent (56,57). Additionally, the volatile anesthetic isoflurane also shows stereoselectivity. The (3)-enantiomer is the more active (58). Further evidence that proteins might serve as appropriate targets for general anesthetics come from observations that anesthetics inhibit the activity of the enzyme luciferase. The potencies parallel the anesthetic activities closely (59,60). [Pg.277]

Tocainide is rapidly and well absorbed from the GI tract and undergoes very fitde hepatic first-pass metabolism. Unlike lidocaine which is - 30% bioavailable, tocainide s availability approaches 100% of the administered dose. Eood delays absorption and decreases plasma levels but does not affect bio availability. Less than 10% of the dmg is bound to plasma proteins. Therapeutic plasma concentrations are 3—9 jig/mL. Toxic plasma levels are >10 fig/mL. Peak plasma concentrations are achieved in 0.5—2 h. About 30—40% of tocainide is metabolized in the fiver by deamination and glucuronidation to inactive metabolites. The metabolism is stereoselective and the steady-state plasma concentration of the (3)-(—) enantiomer is about four times that of the (R)-(+) enantiomer. About 50% of the tocainide dose is efirninated by the kidneys unchanged, and the rest is efirninated as metabolites. The elimination half-life of tocainide is about 15 h, and is prolonged in patients with renal disease (1,2,23). [Pg.113]

Although estrone and estradiol (26) have both been isolated from human urine, it has recently been shown that it is the latter that is the active compound that binds to the so-called estrogen receptor protein. Reduction of estrone with any of a large number of reducing agents (for example, any of the complex metal hydrides) leads cleanly to estradiol. This high degree of stereoselectivity to afford the product of attack at the alpha side of the molecule is characteristic of many reactions of steroids. [Pg.161]

One of the most direct questions to ask in the perspective of enzyme design is whether an already existing protein with a binding pocket might be turned into a new catalyst by introducing catalytic residues directly, rather than by the elaborated TSA mimicry approach used for catalytic antibodies, hoping to create a new biocatalyst that could harness both the activity and the selectivity, in particular stereoselectivity, that is possible with enzymes. [Pg.69]

A representative set of a- and -keto esters was also tested as substrates (total 11) for each purified fusion protein (Figure 8.13b,c) [9bj. The stereoselectivities of -keto ester reductions depended both on the identity of the enzyme and the substrate stmcture, and some reductases yielded both l- and o-alcohols with high stereoselectivities. While a-keto esters were generally reduced with lower enantioselec-tivities, it was possible to identify pairs of yeast reductases that delivered both alcohol antipodes in optically pure form. These results demonstrate the power of genomic fusion protein libraries to identify appropriate biocatalysts rapidly and expedite process development. [Pg.201]

Since most synthetic applications require enzymes catalyzing nonnatural substrates, their properties often have to be improved. One way to achieve this is to optimize reaction conditions such as pH, temperature, solvents, additives, etc. [6-9]. Another way is to modulate the substrates without compromising the synthetic efficiency of the overall reaction [10]. In most cases for commercial manufacturing, however, the protein sequences have to be altered to enhance reactivity, stereoselectivity and stability. It was estimated that over 30 commercial enzymes worldwide have been engineered for industrial applications [11]. Precise prediction of which amino acids to mutate is difficult to achieve. Since the mid 1990s, directed evolution... [Pg.17]

Wu, S., Fallon, R.D. and Payne, M.S. (1997) Over-production of stereoselective nitrile hydratase from Pseudomonas putida 5B in Pichia pastoris activity requires a novel downstream protein. Applied Microbiology and Biotechnology, 48 (6), 704—708. [Pg.53]

These model experiments involving e.e. amplification of amino adds during polymerization admittedly need prebiotically unrealistic substrates as well as carefully contrived experimental conditions. Nevertheless, it is noteworthy that both secondary structures of proteins, a-helices, and P-sheets have been found capable of acting stereoselectively to provide e.e. enhancements during these model polymerizations. [Pg.188]

Ziegelman-Fjeld, K., Musa, M., Phillips, R., Zeikus, J. and Vieille, C., A Thermoanaerobacter ethanolicus secondary alcohol dehydrogenase mutant derivative highly active and stereoselective on phenylacetone and benzylacetone. Protein Eng. Des. Set, 2007, 20, 47-55. [Pg.286]

Selective labelling of the two diastereotopic methyl groups of i-leucine (144) has enabled their fates during secondary metabolic reactions to be elucidated [66]. Moreover, in the context of protein interactions, differentiation of the leucine pro-R and pro-S methyl groups in protein NMR spectra allows molecular recognition phenomena to be studied [67]. Recently, efficient routes to both forms of Relabeled leucine, based on application of an auxiliary-controlled stereoselective conjugate addition reaction (Scheme 6.27) have been described [68]. Thus, starting... [Pg.208]

To explain the observed optical induction, a substrate was incorporated into the molecular model of the protein. A substrate such as a-ketoglutarate could be included in the protein model with a geometry that allowed stereoselective protonation of the quinoid intermediate by solvent, consistent with the enantiomeric excess (ee) of the 1-stereoisomer product. Moreover, the geometry consistent with production of the d-enantiomer appeared too sterically crowded for most substrates. However, pyruvic acid, which was the only substrate to favor the d-enantiomer product, was small enough to adopt the alternative geometry and also had the potential to interact with an arginine group. [Pg.11]

DIrIgent protein Free radical capture and stereoselective coupling... [Pg.188]


See other pages where Proteins stereoselective is mentioned: [Pg.239]    [Pg.239]    [Pg.255]    [Pg.259]    [Pg.272]    [Pg.395]    [Pg.162]    [Pg.201]    [Pg.230]    [Pg.264]    [Pg.286]    [Pg.117]    [Pg.293]    [Pg.294]    [Pg.296]    [Pg.298]    [Pg.298]    [Pg.299]    [Pg.93]    [Pg.200]    [Pg.144]    [Pg.145]    [Pg.234]    [Pg.89]    [Pg.275]    [Pg.250]    [Pg.130]    [Pg.118]    [Pg.37]    [Pg.183]    [Pg.547]    [Pg.108]    [Pg.16]    [Pg.181]    [Pg.331]    [Pg.162]    [Pg.9]    [Pg.186]   
See also in sourсe #XX -- [ Pg.6 ]




SEARCH



© 2024 chempedia.info